Jpmorgan Chase & CO Becton Dickinson & CO Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,018,211 shares of BDX stock, worth $915 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,018,211
Previous 4,461,578
9.94%
Holding current value
$915 Million
Previous $1.04 Billion
7.09%
% of portfolio
0.08%
Previous 0.09%
Shares
14 transactions
Others Institutions Holding BDX
# of Institutions
1,738Shares Held
249MCall Options Held
690KPut Options Held
787K-
Vanguard Group Inc Valley Forge, PA26.6MShares$6.05 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.07 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$3.18 Billion0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13.6MShares$3.1 Billion0.38% of portfolio
-
Morgan Stanley New York, NY11MShares$2.5 Billion0.2% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...